NewGenIvf Group (NASDAQ:NIVF) Shares Down 4.3% – Time to Sell?

NewGenIvf Group Limited (NASDAQ:NIVFGet Free Report) dropped 4.3% during mid-day trading on Tuesday . The company traded as low as $0.8465 and last traded at $0.8611. Approximately 47,785 shares changed hands during mid-day trading, a decline of 97% from the average daily volume of 1,532,745 shares. The stock had previously closed at $0.90.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, NewGenIvf Group currently has a consensus rating of “Sell”.

Read Our Latest Report on NIVF

NewGenIvf Group Stock Up 51.5%

The stock’s fifty day moving average price is $1.78 and its two-hundred day moving average price is $7.90. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16.

NewGenIvf Group (NASDAQ:NIVFGet Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million for the quarter. On average, research analysts forecast that NewGenIvf Group Limited will post 4.74 earnings per share for the current year.

About NewGenIvf Group

(Get Free Report)

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.

Recommended Stories

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.